19 November 2026 Sydney, Australia Nyrada Annual General Meeting Results Nyrada Inc. (ASX:NYR), a clinical-stage biotechnology company focused on developing Transient Receptor Potential Canonical (TRPC) ion channel inhibitors to treat a range of medical conditions, announces the results of...
Results of Meeting
Filed with ASX · · 5 pages · English
Release
In the deck
Earlier from Nyrada
- Presentation - Bell Potter Healthcare Conference 2026
- Quotation of Attaching Options
- Update - Proposed issue of securities - NYR
- Quotation of New Options
- Notice of Initial Substantial Holding - J Moore
Follow Nyrada into a list and get an email when it puts out news.
Follow Nyrada